4.3 Article

Validation of algorithms to identify knee osteoarthritis patients in the claims database

Journal

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
Volume 22, Issue 5, Pages 890-896

Publisher

WILEY
DOI: 10.1111/1756-185X.13470

Keywords

claims data; diagnostic codes; osteoarthritis; validation

Categories

Funding

  1. Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HC15C3388]

Ask authors/readers for more resources

Background To identify knee osteoarthritis (OA) patients among OA patients in the claims database. Methods All patients with OA diagnostic codes for any sites (M15 to M19) in 2014 were recruited from a single academic referral hospital. After excluding patients who had inflammatory arthritis or were less than 50 years of age, we identified data for the overall OA population. Radiographic knee OA of Kellgren and Lawrence grades >= 2 is considered the gold standard for knee OA, and we evaluated the sensitivity, specificity, and positive predictive value (PPV) of three operational definitions using the diagnostic codes in the claims database. The operational definitions were: (1) gonarthrosis (M17); (2) any site of OA (M15 to M19) with knee X-ray; and (3) (1) or (2). Results A total of 7959 OA patients were included in this study of whom 74.5% were women. The PPV of gonarthrosis (M17) was 0.67 (95% CI 0.65-0.69), and sensitivity was 0.44 (95% CI 0.42-0.46). The PPV and sensitivity of any OA site (M15 to M19) with knee X-ray were 0.65 (95% CI 0.62-0.67), and 0.37 (95% CI 0.35-0.39), respectively. When knee OA was defined as satisfying either of the two above definitions, PPV was 0.63 (95% CI 0.62-0.65) and sensitivity 0.55 (95% CI 0.53-0.57). Conclusions Knee OA patients can be identified in a claims database using the algorithms of gonarthrosis (M17) or any site of OA (M15 to M19) with a performed knee X-ray.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Public, Environmental & Occupational Health

Validation of claims-based algorithms for psoriatic arthritis

Hemin Lee, Julia A. Ford, Yinzhu Jin, Soo-Kyung Cho, Adrian J. Santiago Ortiz, Angela Y. Tong, Seoyoung C. Kim

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2020)

Article Multidisciplinary Sciences

Factors for starting biosimilar TNF inhibitors in patients with rheumatic diseases in the real world

Yoon-Kyoung Sung, Sun-Young Jung, Hyoungyoung Kim, Seongmi Choi, Seul Gi Im, Yu Sang Lee, Eun Jin Jang, Soo-Kyung Cho

PLOS ONE (2020)

Article Rheumatology

Temporal relationship between idiopathic inflammatory myopathies and malignancies and its mortality: a nationwide population-based study

Yoon-Kyoung Sung, Sun-Young Jung, Hyoungyoung Kim, Seongmi Choi, Seul Gi Im, Eom Ji Cha, Eun Jin Jang, Dae-Hyun Yoo, Soo-Kyung Cho

CLINICAL RHEUMATOLOGY (2020)

Article Public, Environmental & Occupational Health

Validation of claims-based algorithms to identify patients with psoriasis

Hemin Lee, Mengdong He, Soo-Kyung Cho, Lily Bessette, Angela Y. Tong, Joseph F. Merola, Lani R. Wegrzyn, Ryan D. Kilpatrick, Seoyoung C. Kim

Summary: Nine claims-based algorithms were developed to accurately identify patients with psoriasis using a combination of ICD-9 codes, specialist visits, and medication dispensing. The algorithms showed moderate-to-high positive predictive value in identifying psoriasis patients.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2021)

Article Medicine, General & Internal

Risk of Non-Vertebral Fracture in Gout Compared to Rheumatoid Arthritis

Soo-Kyung Cho, Jun Liu, Yinzhu Jin, Seoyoung C. Kim

Summary: In this study comparing patients with gout and rheumatoid arthritis, gout was associated with a slightly decreased risk of non-vertebral and hip fractures compared to rheumatoid arthritis. Non-vertebral fractures were still common in both gout and rheumatoid arthritis populations.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Rheumatology

Risk factors for herpes zoster in Korean patients with rheumatoid arthritis treated with JAK inhibitor: a nested case-control study

Yeo-Jin Song, Soo-Kyung Cho, Hyoungyoung Kim, Hye Won Kim, Eunwoo Nam, Chan-Bum Choi, Tae-Hwan Kim, Jae-Bum Jun, Sang-Cheol Bae, Dae Hyun Yoo, Yoon-Kyoung Sung

Summary: In Korean patients with rheumatoid arthritis, the use of Janus kinase inhibitors (JAKis) was not associated with an increased risk of herpes zoster (HZ) development. However, having a duration of rheumatoid arthritis less than 10 years and having received three or more previous targeted therapies were identified as risk factors for HZ. Among JAKi users, higher disease activity score and having received three or more previous targeted therapies were additional risk factors for HZ.

RMD OPEN (2022)

Article Rheumatology

Validation of the Korean Leeds satisfaction questionnaire in rheumatoid arthritis with Rasch models

Soo-Kyung Cho, Hyoungyoung Kim, Yeo-Jin Song, Eunwoo Nam, Bethan Jones, Mwidimi Ndosi, Yoo-Kyoung Sung

Summary: The cross-cultural adaptation and validation of the Leeds Satisfaction Questionnaire (LSQ) for patients with rheumatoid arthritis (RA) in Korea were conducted. The results showed that the Korean-LSQ has good reliability and construct validity, and it is a valid and reliable tool for measuring satisfaction with care in Korean patients with RA.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2022)

Article Rheumatology

Association between malignancy risk and Janus kinase inhibitors versus tumour necrosis factor inhibitors in Korean patients with rheumatoid arthritis: a nationwide population-based study

Yeo-Jin Song, Soo-Kyung Cho, Seung-Hun You, Jeong-Yeon Kim, Hyoungyoung Kim, Sun-Young Jung, Yoon-Kyoung Sung

Summary: This study aimed to compare the risk of malignancy in Korean patients with rheumatoid arthritis (RA) receiving Janus kinase inhibitors (JAKis) versus tumor necrosis factor inhibitors (TNFis). The results showed that the use of JAKis was not associated with an increased risk of malignancy compared to TNFis in Korean patients with RA.

RMD OPEN (2022)

Article Rheumatology

MUC5B promoter variant rs35705950, rare but significant susceptibility locus in rheumatoid arthritis-interstitial lung disease with usual interstitial pneumonia in Asian populations

Young Bin Joo, Soo Min Ahn, So-Young Bang, Youngho Park, Su Jin Hong, Youkyung Lee, Soo-Kyung Cho, Chan-Bum Choi, Yoon-Kyoung Sung, Tae-Hwan Kim, Jae-Bum Jun, Dae Hyun Yoo, Sang-Cheol Bae, Hye-Soon Lee

Summary: The MUC5B variant rs35705950 is a rare but significant risk factor for Asian patients with RA-ILD with usual interstitial pneumonia (UIP), suggesting a shared genetic background between Asian and Western populations.

RMD OPEN (2022)

Article Medicine, General & Internal

COX-2 Inhibitor Use as an Early Treatment Option for Knee Osteoarthritis Patients in Korea: A Population-Based Cross-Sectional Study

Soo-Kyung Cho, Seongmi Choi, Hyoungyoung Kim, Yeo-Jin Song, Sun-Young Jung, Eun Jin Jang, Yoon-Kyoung Sung

Summary: In Korea, the use of COX-2 inhibitors as an initial treatment for knee osteoarthritis patients has increased rapidly, but it does not appear to reduce the usage of non-selective NSAIDs and analgesics.

JOURNAL OF KOREAN MEDICAL SCIENCE (2022)

Article Medicine, General & Internal

Fracture Risk and Its Prevention Patterns in Korean Patients with Polymyalgia Rheumatica: a Retrospective Cohort Study

Bora Nam, Yoon-Kyoung Sung, Chan-Bum Choi, Tae-Hwan Kim, Jae-Bum Jun, Sang-Cheol Bae, Dae-Hyun Yoo, Soo-Kyung Cho

Summary: The study evaluated the incidence of fractures and risk factors in Korean PMR patients, finding that female sex, older age, longer follow-up duration, and increased glucocorticoid dose were risk factors for fractures.

JOURNAL OF KOREAN MEDICAL SCIENCE (2021)

Article Rheumatology

Comparison of healthcare resource utilization and medical costs between patients with seropositive and seronegative rheumatoid arthritis

Hyoungyoung Kim, Soo-Kyung Cho, Seongmi Choi, Seul Gi Im, Sun-Young Jung, Eun Jin Jang, Yoon-Kyoung Sung

Summary: Patients with seropositive rheumatoid arthritis (SPRA) utilized more methotrexate and biologic agents, had higher number of RA-related outpatient visits, and incurred higher annual medical costs compared to those with seronegative RA (SNRA). The incremental cost of seropositivity on total medical costs of RA patients increased as costs approached the upper quantile. Direct medical costs for both groups increased between 2012 and 2016, with a higher percentage increase in the SNRA group.

THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2021)

Review Endocrinology & Metabolism

Update on Glucocorticoid Induced Osteoporosis

Soo-Kyung Cho, Yoon-Kyoung Sung

Summary: Glucocorticoids are commonly used to treat autoimmune and inflammatory diseases, but can have adverse effects on bone health, leading to glucocorticoid-induced osteoporosis. Early risk assessment and intervention are crucial in preventing fractures. Bisphosphonates are recommended as the first-line therapy for prevention and treatment of this condition.

ENDOCRINOLOGY AND METABOLISM (2021)

Article Medicine, General & Internal

Uptake of Biosimilars and Its Economic Implication for the Treatment of Patients with Rheumatoid Arthritis in Korea

Soo-Kyung Cho, Sun-Young Jung, Hyoungyoung Kim, Yeo-Jin Song, Kyungeun Lee, Yoon-Kyoung Sung

Summary: Since the introduction of biosimilar TNFis in 2012, their usage has steadily increased among RA patients in Korea, leading to a decrease in medical costs for both originator and biosimilar TNFis users.

JOURNAL OF KOREAN MEDICAL SCIENCE (2021)

Article Medicine, General & Internal

Risk of Tuberculosis Development in Patients with Rheumatoid Arthritis Receiving Targeted Therapy: a Prospective Single Center Cohort Study

Yeo-Jin Song, Soo-Kyung Cho, Hyoungyoung Kim, Hye Won Kim, Eunwoo Nam, Sang-Cheol Bae, Dae Hyun Yoo, Yoon-Kyoung Sung

Summary: The study evaluated the effectiveness of diagnosing and treating LTBI in RA patients receiving targeted therapy in Korea, and estimated the risk of TB development. Although the prevalence of LTBI was slightly elevated in RA patients starting targeted therapy, Korean guidelines were effective in preventing LTBI from progressing to active TB.

JOURNAL OF KOREAN MEDICAL SCIENCE (2021)

No Data Available